MB Growth Partners
MB Growth Partners is an investment fund focused on identifying and supporting growing businesses in New England. Established in 1992, it has been active in providing private capital for over a decade, investing between $500,000 and $5 million in various ventures. The firm emphasizes opportunities in the technology sector, aiming to foster innovation and growth in this area. Additionally, MB Venture Partners, a related entity founded in 2001 and based in Memphis, Tennessee, specializes in early-stage investments in the life sciences sector, particularly in medical devices and biotechnology. This firm seeks to capitalize on product solutions for musculoskeletal diseases and leverages extensive experience and relationships in the industry to guide its investments.
Salient Surgical Technologies, Inc., established in 1999, is a privately held medical technology company that specializes in advanced energy devices for surgical procedures. Initially focusing on monopolar electrosurgical devices for liver cancer treatment, the company has since developed the AQUAMANTYS® System, which features bipolar electrosurgical technology. This system is designed to minimize surgical blood loss through its patented TRANSCOLLATION® technology, which enables the haemostatic sealing of soft tissue and bone. The AQUAMANTYS System is utilized in various surgeries, including orthopaedic reconstruction, spine surgery, orthopaedic trauma, and surgical oncology. Salient's products are distributed in the United States, Europe, and Asia, benefiting hospitals, healthcare providers, and patients by enhancing clinical outcomes and reducing costs. To date, over 500,000 patients have undergone treatment using TRANSCOLLATION technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.